Location: Alicante
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Alicante
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors. Phase N/A · Hospital General Universitario de Alicante · Spanish Oncology Genito-Urinary Group · NCT06724159 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in Phase 3 · Pfizer · NCT06758401 Effect of PRP in Donor Semen During Cryoprervation Phase N/A · IVI Alicante · Instituto Valenciano de Infertilidad, IVI Alicante · NCT07504575 Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients Phase N/A · Instituto Bernabeu · Instituto Bernabeu · NCT07364526 Randomization of Single vs Multiple Arterial Grafts NA · Hospital Univeritario Del Vinalopo · Weill Medical College of Cornell University · NCT03217006 Spanish Registry of Esophagogastric Cancer Phase N/A · Hospital General Universitario de Alicante · Fundación Sociedad Española de Oncologia Médica · NCT04958720 Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management Phase 2 · Hospital General Universitario Dr. Balmis · SOLTI Breast Cancer Research Group · NCT07371585 A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Phase N/A · Hospital General Universitario Dr. Balmis · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615 Body Composition and Lifestyles in Athletes With Disabilities Phase N/A · University of Alicante · NCT07464899 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Phase 3 · Hosp. Gral. Univ. Dr. Balmis · Janssen Research & Development, LLC · NCT07499232 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Phase N/A · Hospital General de Alicante;servicio de digestivo · Hoffmann-La Roche · NCT07284121 PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS Phase 2 · Hospital General Universitario Dr. Balmis de Alicante · PhenoNet, Inc. · NCT07142291 Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy Phase 2 · Hospital General Universitario de Alicante · Fundación GECP · NCT05398094 Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis NA · Grupo Español de Investigación en Diagnóstico y Tratamiento · NCT07465848 Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants Phase N/A · Clínica Dental esteve · Aula Dental Avanzada · NCT05500755 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors Phase 1/Phase 2 · Artios Pharma Ltd · NCT04657068 Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chron Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06865651 Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Phase 3 · Hospital General Universitario de Alicante · Fundación GECP · NCT06431633 Pan Tumor Rollover Study Phase 2 · Local Institution - 0173 · Bristol-Myers Squibb · NCT03899155 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi Phase 3 · Research Site · AstraZeneca · NCT06357533 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate Phase N/A · Hospital General Universitario Dr. Balmis-Site Number: 72400 · Sanofi · NCT07290803 POS-ARI-ER Observational Study of Acute Respiratory Infections Phase N/A · Hospital General Universitario de Alicante · European Clinical Research Alliance for Infectious Diseases · NCT05814237 Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer Phase 2 · Hospital General Universitario Dr. Balmis · MedSIR · NCT07195227 Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC) Phase 4 · Hospital Universitario de Fuenlabrada · NCT05250648 Thoracic Tumours Register Phase N/A · Hospital General de Alicante · Spanish Lung Cancer Group · NCT02941458 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Phase 3 · Research Site · AstraZeneca · NCT05952557 A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed No Phase 3 · Hospital General Universitario Dr. Balmis de Alicante · ETOP IBCSG Partners Foundation · NCT06931717 "PROTECT-ICU: Impact of an Educational Intervention NA · Carola Giménez-Esparza Vich · NCT07542613 Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both NA · Hospital Universitario San Juan Alicante · Fundación EPIC · NCT07190690 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson' Phase 3 · Hoffmann-La Roche · NCT07174310
Look up another city
Look up another condition